No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs7646694 |
chr3:105212993-105212994 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs558684206 |
chr3:105213022-105213023 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs199834119 |
chr3:105213023-105213024 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs112027187 |
chr3:105213031-105213032 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs368605915 |
chr3:105213035-105213036 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs541072443 |
chr3:105213124-105213125 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs559227892 |
chr3:105213143-105213144 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs73006123 |
chr3:105213179-105213180 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs541455510 |
chr3:105213209-105213210 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs562968205 |
chr3:105213217-105213218 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs150368715 |
chr3:105213234-105213235 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs138157015 |
chr3:105213235-105213236 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs147247427 |
chr3:105213270-105213271 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs550216845 |
chr3:105213330-105213331 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs149133505 |
chr3:105213414-105213415 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs182990523 |
chr3:105213416-105213417 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs560259652 |
chr3:105213429-105213430 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs138944739 |
chr3:105213511-105213512 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs77344640 |
chr3:105213542-105213543 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs146601431 |
chr3:105213562-105213563 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs548572879 |
chr3:105213567-105213568 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs570080186 |
chr3:105213589-105213590 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs370843857 |
chr3:105213599-105213600 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs55820772 |
chr3:105213678-105213679 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs558575749 |
chr3:105213689-105213690 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs576961590 |
chr3:105213702-105213703 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs78575265 |
chr3:105213785-105213786 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs534553467 |
chr3:105213805-105213806 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs73189046 |
chr3:105213861-105213862 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs574170141 |
chr3:105213895-105213896 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs541542021 |
chr3:105213910-105213911 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs556501203 |
chr3:105213928-105213929 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs187757065 |
chr3:105213932-105213933 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs193141698 |
chr3:105213947-105213948 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs182649313 |
chr3:105213948-105213949 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs187608468 |
chr3:105214016-105214017 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs368901627 |
chr3:105214052-105214053 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs560008150 |
chr3:105214077-105214078 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs114413112 |
chr3:105214114-105214115 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs192860635 |
chr3:105214153-105214154 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs570015088 |
chr3:105214161-105214162 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs530854266 |
chr3:105214182-105214183 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs370998815 |
chr3:105214248-105214249 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs374374321 |
chr3:105214264-105214265 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs71111363 |
chr3:105214285-105214286 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs398082328 |
chr3:105214293-105214294 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs397990704 |
chr3:105214294-105214295 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs201517818 |
chr3:105214295-105214296 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs367553869 |
chr3:105214306-105214307 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs184681117 |
chr3:105214319-105214320 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|